Interstitial lung disease in patients with non-small-cell lung cancer treated with epidermal growth factor receptor inhibitors (Q36487093)

14 August 2017

Interstitial lung disease in patients with non-small-cell lung cancer treated with epidermal growth factor receptor inhibitors (English)

1 reference

interstitial lung disease

14 August 2017

1 reference

2

Thierry Le Chevalier

1 reference

14 August 2017

1

Masahiro Tsuboi

1 reference

PubMed ID

16720916

14 August 2017

language of work or name

1 reference

1 January 2006

1 reference

14 August 2017

1 reference

14 August 2017

23

1 reference

14 August 2017

161-170

1 reference

14 August 2017

2

1 reference

https://scigraph.springernature.com/pub.10.1385/mo:23:2:161

14 August 2017

0 references

cites work

Diagnostic approach to the patient with diffuse lung disease

1 reference

12 December 2020

Gefitinib in combination with gemcitabine and cisplatin in advanced non-small-cell lung cancer: a phase III trial--INTACT 1.

1 reference

12 December 2020

Mitochondria-mediated apoptosis of lung epithelial cells in idiopathic interstitial pneumonias

1 reference

12 December 2020

Phase II studies of gemcitabine for non-small cell lung cancer in Japan.

1 reference

12 December 2020

Risk factors of pneumonitis following chemoradiotherapy for lung cancer

1 reference

12 December 2020

Involvement of the epidermal growth factor receptor in epithelial repair in asthma

1 reference

12 December 2020

Life-threatening hypersensitivity pneumonitis induced by docetaxel (taxotere)

1 reference

12 December 2020

Pulmonary toxicities of cancer therapy.

1 reference

12 December 2020

A phase II study of vinorelbine, a new derivative of vinca alkaloid, for previously untreated advanced non-small cell lung cancer. Japan Vinorelbine Lung Cancer Study Group

1 reference

12 December 2020

A multicenter phase II trial of vinorelbine plus gemcitabine in previously untreated inoperable (Stage IIIB/IV) non-small cell lung cancer

1 reference

12 December 2020

Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer (The IDEAL 1 Trial) [corrected].

1 reference

12 December 2020

Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: a randomized trial

1 reference

12 December 2020

Interstitial lung disease associated with drug therapy

1 reference

12 December 2020

Association of malignancy with diseases causing interstitial pulmonary changes

1 reference

12 December 2020

Drug-induced pneumonitis: thin-section CT findings in 60 patients.

1 reference

12 December 2020

Early detection of lung cancer: clinical perspectives of recent advances in biology and radiology

1 reference

12 December 2020

Cell cycle kinetics in the alveolar epithelium

1 reference

12 December 2020

Evidence of type II pneumocyte apoptosis in the pathogenesis of idiopathic pulmonary fibrosis (IFP)/usual interstitial pneumonia (UIP).

1 reference

12 December 2020

Phase II study of docetaxel and gemcitabine combination chemotherapy in non-small-cell lung cancer patients failing previous chemotherapy

1 reference

12 December 2020

Phase I/IIa study of concurrent paclitaxel and cisplatin with radiation therapy in locally advanced non-small cell lung cancer: analysis of early and late pulmonary morbidity

1 reference

12 December 2020

Summer-type hypersensitivity pneumonitis. A unique disease in Japan

1 reference

12 December 2020

Randomized phase III study of chemoradiation with or without amifostine for patients with favorable performance status inoperable stage II-III non-small cell lung cancer: preliminary results

1 reference

12 December 2020

Severe lymphocytopenia and interstitial pneumonia in patients treated with paclitaxel and simultaneous radiotherapy for non-small-cell lung cancer

1 reference

12 December 2020

Targeting the epidermal growth factor receptor in cancer: apoptosis takes center stage.

1 reference

12 December 2020

Computed tomography to assess pulmonary injury associated with concurrent chemo-radiotherapy for inoperable non-small cell lung cancer

1 reference

12 December 2020

Japanese summer-type hypersensitivity pneumonitis. Geographic distribution, home environment, and clinical characteristics of 621 cases

1 reference

12 December 2020

Gefitinib in combination with paclitaxel and carboplatin in advanced non-small-cell lung cancer: a phase III trial--INTACT 2.

1 reference

12 December 2020

Phase II study of 3-hour infusion of paclitaxel in patients with previously untreated stage III and IV non-small cell lung cancer. West Japan Lung Cancer Group

1 reference

12 December 2020

Protection from lethal apoptosis in lipopolysaccharide-induced acute lung injury in mice by a caspase inhibitor

1 reference

12 December 2020

Docetaxel and interstitial pulmonary injury

1 reference

12 December 2020

Dose-finding, pharmacokinetic and phase II study of docetaxel in combination with gemcitabine in patients with inoperable non-small cell lung cancer.

1 reference

12 December 2020

Severe acute interstitial pneumonia and gefitinib

1 reference

12 December 2020

Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer

1 reference

12 December 2020

The epidemiology of interstitial lung disease and its association with lung cancer

1 reference

12 December 2020

Idiopathic pulmonary fibrosis and malignancy

1 reference

12 December 2020

The alveolar type II cell is a pluripotential stem cell in the genesis of human adenocarcinomas and squamous cell carcinomas.

1 reference

12 December 2020

Treatment of non-small-cell lung cancer: a perspective on the recent advances and the experience with gefitinib

1 reference

12 December 2020

Distribution of proliferating-cell nuclear antigen and epidermal growth factor receptor in intraepithelial squamous cell lesions of human bronchus.

1 reference

12 December 2020

Gemcitabine and paclitaxel associated pneumonitis in non-small cell lung cancer: report of a phase I/II dose-escalating study

1 reference

12 December 2020

A phase II study of CPT-11, a new derivative of camptothecin, for previously untreated non-small-cell lung cancer

1 reference

12 December 2020

Alveolar epithelial type II cell: defender of the alveolus revisited

1 reference

12 December 2020

Sequential chemo- and radiochemotherapy with weekly paclitaxel (Taxol) and 3D-conformal radiotherapy of stage III inoperable non-small cell lung cancer. Results of a dose escalation study

1 reference

12 December 2020

Lung cancer and cryptogenic fibrosing alveolitis. A population-based cohort study

1 reference

12 December 2020

Radiation-induced and chemotherapy-induced pulmonary injury

1 reference

12 December 2020

Overview of the tolerability of gefitinib (IRESSA) monotherapy : clinical experience in non-small-cell lung cancer

1 reference

12 December 2020

A phase II study of weekly gemcitabine and paclitaxel in patients with previously untreated stage IIIb and IV non-small cell lung cancer

1 reference

12 December 2020

Phase II trial of docetaxel in previously untreated advanced non-small-cell lung cancer: a Japanese cooperative study

1 reference

12 December 2020

Understanding the mechanisms of drug-associated interstitial lung disease

1 reference

12 December 2020

Phase II study of docetaxel and ifosfamide combination chemotherapy in non-small-cell lung cancer patients failing previous chemotherapy with or without paclitaxel

1 reference

12 December 2020

Distribution of epidermal growth factor and epidermal growth factor receptor in human lung: immunohistochemical and immunoelectron-microscopic studies

1 reference

12 December 2020

1 reference

12 December 2020

Apoptosis in lung fibrosis and repair

1 reference

12 December 2020

Expression of c-erbB receptors and ligands in human bronchial mucosa

1 reference

12 December 2020

Radiation recall dermatitis and pneumonitis in a patient treated with paclitaxel

1 reference

12 December 2020

Diagnosis and management of drug-associated interstitial lung disease

1 reference

12 December 2020

Identifiers

DOI

10.1385/MO:23:2:161

1 reference

PubMed ID

16720916

Dimensions Publication ID

14 August 2017

0 references

1 reference

PubMed ID

16720916